Your search returned 8 results.

Results
	1.	Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33). [electronic resource] by Loibl, Sibylle Mueller, Volkmar von Minckwitz, Gunter Conrad, Bettina Koehne, Claus-Henning Kremers, Stephan Forstbauer, Helmut Linder, Mattea Nekljudova, Valentina Moebus, Volker Producer: 20120424 In: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma. [electronic resource] by Mey, Ulrich J M Maier, Anna Schmidt-Wolf, Ingo G H Ziske, Carsten Forstbauer, Helmut Banat, Gamal-Andre Reber, Michael Strehl, John W Gorschlueter, Marcus Producer: 20071113 In: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial. [electronic resource] by Schwentner, Lukas Harbeck, Nadia Singer, Susanne Eichler, Martin Rack, Brigitte Forstbauer, Helmut Wischnik, Arthur Scholz, Christoph Huober, Jens Friedl, Thomas W P Weissenbacher, Tobias Härtl, Kristin Kiechle, Marion Janni, Wolfgang Fink, Visnja Producer: 20170306 In: Breast (Edinburgh, Scotland) vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial. [electronic resource] by Jueckstock, Julia Rack, Brigitte Friedl, Thomas W P Scholz, Christoph Steidl, Julia Trapp, Elisabeth Tesch, Hans Forstbauer, Helmut Lorenz, Ralf Rezai, Mahdi Häberle, Lothar Alunni-Fabbroni, Marianna Schneeweiss, Andreas Beckmann, Matthias W Lichtenegger, Werner Fasching, Peter A Pantel, Klaus Janni, Wolfgang Producer: 20171003 In: BMC cancer vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial. [electronic resource] by Gluz, Oleg Kolberg-Liedtke, Cornelia Prat, Aleix Christgen, Matthias Gebauer, Daniel Kates, Ronald Paré, Laia Grischke, Eva-Maria Forstbauer, Helmut Braun, Michael Warm, Mathias Hackmann, John Uleer, Christoph Aktas, Bahriye Schumacher, Claudia Kuemmel, Sherko Wuerstlein, Rachel Pelz, Enrico Nitz, Ulrike Kreipe, Hans Heinrich Harbeck, Nadia Producer: 20200214 In: International journal of cancer vol. 146 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer. [electronic resource] by von Minckwitz, Gunter Möbus, Volker Schneeweiss, Andreas Huober, Jens Thomssen, Christoph Untch, Michael Jackisch, Christian Diel, Ingo J Elling, Dirk Conrad, Bettina Kreienberg, Rolf Müller, Volkmar Lück, Hans-Joachim Bauerfeind, Ingo Clemens, Michael Schmidt, Marcus Noeding, Stefanie Forstbauer, Helmut Barinoff, Jana Belau, Antje Nekljudova, Valentina Harbeck, Nadia Loibl, Sibylle Producer: 20131126 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. [electronic resource] by Harbeck, Nadia Gluz, Oleg Christgen, Matthias Kates, Ronald Ernest Braun, Michael Küemmel, Sherko Schumacher, Claudia Potenberg, Jochem Kraemer, Stefan Kleine-Tebbe, Anke Augustin, Doris Aktas, Bahriye Forstbauer, Helmut Tio, Joke von Schumann, Raquel Liedtke, Cornelia Grischke, Eva-Maria Schumacher, Johannes Wuerstlein, Rachel Kreipe, Hans Heinrich Nitz, Ulrike Anneliese Producer: 20170915 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. [electronic resource] by Gluz, Oleg Nitz, Ulrike Liedtke, Cornelia Christgen, Matthias Grischke, Eva-Maria Forstbauer, Helmut Braun, Michael Warm, Mathias Hackmann, John Uleer, Christoph Aktas, Bahriye Schumacher, Claudia Bangemann, Nikola Lindner, Christoph Kuemmel, Sherko Clemens, Michael Potenberg, Jochem Staib, Peter Kohls, Andreas von Schumann, Raquel Kates, Ronald Kates, Ronald Schumacher, Johannes Wuerstlein, Rachel Kreipe, Hans Heinrich Harbeck, Nadia Producer: 20190729 In: Journal of the National Cancer Institute vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)